Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $17.21 ($137,680)
  2. 4 Option exercise Director acquired 1,333 shares (option exercise)
  3. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $17.23 ($137,840)
  4. 4 Open-market buy Director bought 9,506 shares at $16.80 ($159,701)
  5. 4 Planned sale Chief Commercial Officer sold 2,400 shares at $20.05 ($48,120)
  6. 4 Planned sale President/CEO and Board Chair sold 103,900 shares at an average $20.01 ($2,078,984)
  7. 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $17.35 ($156,150)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $18.63 ($149,040)
  16. 4 Option exercise Director acquired 2,000 shares (option exercise)
  17. 4 Option exercise Director acquired 2,000 shares (option exercise)
  18. 4 Option exercise Director acquired 2,000 shares (option exercise)
  19. 4 Option exercise Director acquired 2,000 shares (option exercise)
  20. 4 Option exercise Director acquired 2,000 shares (option exercise)

Page 8 of 17 · 330 filings